LIDOCAINE HYDROCHLO
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
Lidocaine Hydrochloride and Epinephrine, USP, is a parenteral injectable pharmaceutical product containing a 2 percent concentration of lidocaine hydrochloride and a 1:50,000 dilution of epinephrine bitartrate, supplied in 1.7 mL single-dose cartridges. The unit of issue is a package of 50 cartridges, each contained within cardboard boxes featuring five blisters of ten cartridges each. The product must be stored at controlled room temperature below 25°C (77°F), protected from light, and must not be frozen. It is regulated by the FDA and requires a prescription. The item has a non-extendable shelf life of 18 months and must be marked in full compliance with Medical Marking Standard No. 1, superseding all prior references to MIL-STD-129. Packaging and shipping must meet commercial standards, with each unit sealed and protected in suitable containers to ensure safe transport via common carrier, and all exterior containers must meet federal logistics requirements. The procurement is issued under contract SPE2DP-26-T-4213 with a solicitation posted on July 21, 2026, and responses due by July 27, 2026. The quantity required is one unit of issue (50 cartridges), with delivery required within five days of award to the destination at Joint Base Elmendorf-Richardson, Alaska. Delivery is FOB destination and subject to zero variance in quantity. Inspection and acceptance occur upon delivery. The item is classified under NSN 6505-01-576-2767, with procurement reference PR 7017548713. All technical and quality requirements referenced in the DLA Master List are incorporated by reference, and the product must be sourced from approved manufacturers including Dentsply Sirona Inc. with NDC 66312-0181-16. Government use requires adherence to all applicable defense logistics standards, including transport protocols and marking instructions, with a designated point of contact and official delivery address provided for coordination.
General Info
Agency
NAICS
Place of Performance
5250 GIBSON AVE BLDG 5250, JBER, AK, 99506-4400, USSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, USP. RX ONLY<(>,<)>
ADMINISTERED PARENTERALLY BY INJECTION. CONTAINS 2 PERCENT CONCENTRATION
OF LIDOCAINE HYDROCHLORIDE AND 1:50,000 DILUTION OF EPINEPHRINE (AS THE
BITARTRATE). 1.7 ML CARTRIDGE, 50'S. UNIT OF ISSUE IS A PACKAGE
CONTAINING 50 SINGLE DOSE CARTRIDGES (SUPPLIED IN CARDBOARD BOXES
CONTAINING 5 BLISTERS OF 10 X 1.7 ML CARTRIDGES). STORE AT CONTROLLED
ROOM TEMPERATURE, BELOW 25°C (77°F). PROTECT FROM LIGHT. DO NOT PERMIT
TO FREEZE.
...
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. RS013: Shelf-life requirement RS001 for a TYPE I (CODE K) item with a shelf life of 18 months (non-extendable) applies to this item.
... SHALL BE MARKED IAW THE LATEST EDITION OF THE MEDICAL MARKING STANDARD NO. 1. MMS NO. 1 IS AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
BENCO DENTAL SUPPLY CO. 1V865 P/N 4116-609 DENTSPLY SIRONA INC 0KSX4 P/N 22216 DENTSPLY SIRONA INC 0KSX4 P/N NDC66312-0181-16
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
SPE2DP-26-T-4213
SECTION B
PR: 7017548713 PRLI: 0001 CONT’D
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017548713 0001 PG 1.000
NSN/MATERIAL:6505015762767
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:A
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:Z PACKING LEVEL: B
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
PARCEL POST ADDRESS:
FM5000
FM5000 673 MDSS SGSM
5250 GIBSON AVE BLDG 5250
JBER AK 99506-4400
US
FOR TRANSPORTATION SEE DLAD DLAD PROC NOTE C19. FOR FIRST DESTINATION TRANSPORTATION SEE DLAD PROC NOTE
C20 AND CONTRACT
SPE2DP-26-T-4213
SECTION B
PR: 7017548713 PRLI: 0001 CONT’D
FREIGHT SHIPPING ADDRESS:
FM5000
FM5000 673 MDSS SGSM
CP 907 552 8846
5250 GIBSON AVE BLDG 5250
JBER AK 99506
US
M/F: (TCN) FM500061980154
RDD:
PROJ: TP 1
SUPP ADD: SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 03
DIC: A01 DIST: ADV: 2A FC: 6B
Need Ship Date:00/00/0000 Original Required Delivery Date:07/22/2026
SPE2DP-26-T-4213 NSN/Part Number: 6505-01-576-2767 Quantity: 1 PG Purchase Request: 7017548713QTY: 1 Delivery: 5 days ADO
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
